Publications 2022
375.
Massy ZA, Lambert O, Metzger M, Sedki M, Chaubet A, Breuil B, Jaafar A, Tack I, Nguyen-Khoa T, Alves M, Siwy J, Mischak H, Verbeke F, Glorieux G, Herpe YE, Schanstra JP, Stengel B, Klein J; CKD-REIN study group.
Machine Learning-Based Urine Peptidome Analysis to Predict and Understand Mechanisms of Progression to Kidney Failure
Kidney Int Rep. 2022, 8(3):544-555.
374.
Martens DS, Mischak H, Nawrot TS, Staessen JA; FLEMENGHO investigators.
A urinary proteomic marker indicative of premature ageing
Blood Press Monit. 2022, 27(Suppl 1):e9. Epub 2022 Nov 25.
373.
Persu A, Fanelli E, Latosinska A, Mischak H.
The urinary proteomic profile of fibromuscular dysplasia
Blood Press Monit. 2022, 27(Suppl 1):e8-e9. Epub 2022 Nov 25.
372.
Mischak H.
Urinary proteomics for risk stratification
Blood Press Monit. 2022, 27(Suppl 1):e7. Epub 2022 Nov 25.
371.
Piedrafita A, Siwy J, Klein J, Akkari A, Amaya-Garrido A, Mebazaa A, Sanz AB, Breuil B, Montero Herrero L, Marcheix B, Depret F, Fernandez L, Tardif E, Minville V, Alves M, Metzger J; Kidney Attack Study Group; Grossac J, Mischak H, Ortiz A, Gazut S, Schanstra JP, Faguer S.
A universal predictive and mechanistic urinary peptide signature in acute kidney injury
Crit Care. 2022, 26(1):344.
370.
Mengual L, Frantzi M, Mokou M, Ingelmo-Torres M, Vlaming M, Merseburger AS, Roesch MC, Culig Z, Alcaraz A, Vlahou A, Mischak H, Van der Heijden AG.
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients
Br J Cancer. 2022, 127(11):2043-2051. Epub 2022 Oct 3.
369.
Curovic VR, Eickhoff MK, Rönkkö T, Frimodt-Møller M, Hansen TW, Mischak H, Rossing P, Ahluwalia TS, Persson F.
Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial
Diabetes Care. 2022, 45(11):2662-2668.
368.
Staessen JA, Wendt R, Yu YL, Kalbitz S, Thijs L, Siwy J, Raad J, Metzger J, Neuhaus B, Papkalla A, von der Leyen H, Mebazaa A, Dudoignon E, Spasovski G, Milenkova M, Canevska-Taneska A, Salgueira Lazo M, Psichogiou M, Rajzer MW, Fuławka Ł, Dzitkowska-Zabielska M, Weiss G, Feldt T, Stegemann M, Normark J, Zoufaly A, Schmiedel S, Seilmaier M, Rumpf B, Banasik M, Krajewska M, Catanese L, Rupprecht HD, Czerwieńska B, Peters B, Nilsson Å, Rothfuss K, Lübbert C, Mischak H, Beige J; CRIT-CoV-U investigators.
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study
Lancet Digit Health. 2022, 4(10):e727-e737. Epub 2022 Aug 31.
367.
Rambabova-Bushljetik I, Metzger J, Siwy J, Dohcev S, Bushljetikj O, Filipce V, Trajceska L, Mischak H, Spasovski G.
Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients
Nephrol Dial Transplant. 2022, 37(10):2014-2021.
366.
Charalambous D, Christoforou M, Kitiri EN, Andreou M, Partassides D, Papachrysostomou C, Frantzi M, Karikas GA, Pantelidou M.
Antimicrobial Activities of Saponaria cypria Boiss. Root Extracts, and the Identification of Nine Saponins and Six Phenolic Compounds
Molecules. 2022, 27(18):5812.
365.
Frantzi M, Heidegger I, Roesch MC, Gomez-Gomez E, Steiner E, Vlahou A, Mullen W, Guler I, Merseburger AS, Mischak H, Culig Z.
Validation of diagnostic nomograms based on CE-MS urinary biomarkers to detect clinically significant prostate cancer
World J Urol. 2022, 40(9):2195-2203. Epub 2022 Jul 16.
364.
Nicol K, Mansoorian B, Latosinska A, Koutroulaki A, Mullen B, Combet E.
No evidence of differential impact of sunflower and rapeseed oil on biomarkers of coronary artery disease or chronic kidney disease in healthy adults with overweight and obesity: result from a randomised control trial
Eur J Nutr. 2022, 61(6):3119-3133. Epub 2022 Apr 5.
363.
Lygirou V, Fasoulakis K, Stroggilos R, Makridakis M, Latosinska A, Frantzi M, Katafigiotis I, Alamanis C, Stravodimos KG, Constantinides CA, Vlahou A, Zoidakis J.
Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness
Cancers (Basel). 2022, 14(15):3765.
362.
Sanchez-Martin I, Magalhães P, Ranjzad P, Fatmi A, Richard F, Manh TPV, Saurin AJ, Feuillet G, Denis C, Woolf AS, Schanstra JP, Zürbig P, Caubit X, Fasano L.
Haploinsufficiency of the mouse Tshz3 gene leads to kidney defects
Hum Mol Genet. 2022, 31(12):1921-1945.
361.
Stroggilos R, Frantzi M, Zoidakis J, Mokou M, Moulavasilis N, Mavrogeorgis E, Melidi A, Makridakis M, Stravodimos K, Roubelakis MG, Mischak H, Vlahou A.
Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature
Cancers (Basel). 2022, 14(10):2542.
360.
Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S, Efentakis P, Kampoukos S, Kostomitsopoulos N, Vilskersts R, Ikonomidis I, Lambadiari V, Zuurbier CJ, Latosinska A, Vlahou A, Dimitriadis G, Iliodromitis EK, Andreadou I. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Basic Res Cardiol. 2022, 117(1):27.
359.
Jäger M, Latosinska A, Herten M, Busch A, Grupp T, Sowislok A.
The Implant Proteome-The Right Surgical Glue to Fix Titanium Implants In Situ
J Funct Biomater. 2022, 13(2):44.
358.
O'Connell SP, Frantzi M, Latosinska A, Webb M, Mullen W, Pejchinovski M, Salji M, Mischak H, Cooper CS, Clark J, Brewer DS, On Behalf Of The Movember Gap Urine Biomarker Consortium.
A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data
Cancers (Basel). 2022, 14(8):1995.
357.
Wei D, Trenson S, Van Keer JM, Melgarejo J, Cutsforth E, Thijs L, He T, Latosinska A, Ciarka A, Vanassche T, Van Aelst L, Janssens S, Van Cleemput J, Mischak H, Staessen JA, Verhamme P, Zhang ZY.
The novel proteomic signature for cardiac allograft vasculopathy
ESC Heart Fail. 2022, 9(2):1216-1227. Epub 2022 Jan 10.
356.
Mischak H, Kalvodova L.
Interview with Harald Mischak
Proteomics. 2022, 22(3):e2100390.
355.
Tserga A, Pouloudi D, Saulnier-Blache JS, Stroggilos R, Theochari I, Gakiopoulou H, Mischak H, Zoidakis J, Schanstra JP, Vlahou A, Makridakis M.
Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease
Biomedicines. 2022, 10(2):216.
354.
Petra E, Siwy J, Vlahou A, Jankowski J.
Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
PLoS One. 2022, 17(1):e0262667.
353.
Latosinska A, Bruno RM, Pappaccogli M, Bacca A, Beauloye C, Boutouyrie P, Khettab H, Staessen JA, Taddei S, Toubiana L, Vikkula M, Mischak H, Persu A.
Increased Collagen Turnover Is a Feature of Fibromuscular Dysplasia and Associated With Hypertrophic Radial Remodeling: A Pilot, Urine Proteomic Study
Hypertension. 2022, 79(1):93-103. Epub 2021 Nov 17.